Cancer Communications
indexed by SCI
BMC

Important notice

 

 

Cancer Communications is published by Wiley from 1 January 2020. The journal website is available at: https://onlinelibrary.wiley.com/journal/25233548

 

 

Cancer Communications 参与主办第十届广州国际肿瘤学会议,欢迎参会!

Cancer Communications 2021年影响因子突破15分

Cancer Communications 进入2021年中科院期刊分区表医学1区和肿瘤学1区

Cancer Communications 入选中国科协发布的高质量肿瘤学科技期刊T1分级目录

Cancer Communications (CJC) 获评“2019中国最具国际影响力学术期刊”


Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long-term clinical outcomes and health-related quality of life assessment
Chen-hua Yan, Yu Wang, Yu-qian Sun, Yi-fei Cheng, Xiao-dong Mo, Feng-rong Wang, Yu-hong Chen, Yuan-yuan Zhang, Ting-ting Han, Huan Chen, Lan-ping Xu, Xiao-hui Zhang, Kai-yan Liu, Xiao-jun Huang
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/23/2022   doi:10.1002/cac2.12376
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract
Huanwen Wu, Zicheng Yu, Yueping Liu, Lei Guo, Lianghong Teng, Lingchuan Guo, Li Liang, Jing Wang, Jie Gao, Ruiyu Li, Ling Yang, Xiu Nie, Dan Su, Zhiyong Liang
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/20/2022   doi:10.1002/cac2.12372
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, Shengfang Ge, Peiwei Chai, Ai Zhuang, Xianqun Fan
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/20/2022   doi:10.1002/cac2.12374
The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy
Amandine Crombé, Mathtieu Roulleau-Dugage, Antoine Italiano
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/19/2022   doi:10.1002/cac2.12373
Social-epigenetic mediators for racial disparities in pulmonary impairment among childhood cancer survivors
Nan Song, Qian Dong, Cheng Chen, Qian Li, Heather Mulder, Emily Plyler, John Easton, Emily Walker, Scott Olson, Geoffrey Neale, Kevin R. Krull, Deo Kumar Srivastava, Kirsten K. Ness, Jinghui Zhang, Melissa M. Hudson, Leslie L. Robison, I-Chan Huang, Zhaoming Wang
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/18/2022   doi:10.1002/cac2.12371
Malignant transformation by oncogenic K-ras requires IDH2-mediated reductive carboxylation to promote glutamine utilization
Rui Liu, Panpan Liu, Huichang Bi, Jianhua Ling, Huiqin Zhang, Mingquan Zhang, Yumin Hu, Paul J Chiao, Peng Huang, Jinyun Liu
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/17/2022   doi:10.1002/cac2.12369
Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocations
Anna Shmakova, Nikolai Lomov, Vladimir Viushkov, Tatyana Tsfasman, Yana Kozhevnikova, Darina Sokolova, Vadim Pokrovsky, Marina Syrkina, Diego Germini, Mikhail Rubtsov, Yegor Vassetzky
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/17/2022   doi:10.1002/cac2.12370
Current updates of CRISPR/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management
Khaled S. Allemailem, Mohammed A Alsahli, Ahmad Almatroudi, Faris Alrumaihi, Fahd Khaleefah Alkhaleefah, Arshad Husain Rahmani, Amjad Ali Khan
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/9/2022   doi:10.1002/cac2.12366
SDCBP-AS1 destabilizes β-catenin by regulating ubiquitination and SUMOylation of hnRNP K to suppress gastric tumorigenicity and metastasis
Jing Han, Menglin Nie, Cong Chen, Xiaojing Cheng, Ting Guo, Longtao Huangfu, Xiaomei Li, Hong Du, Xiaofang Xing, Jiafu Ji
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/9/2022   doi:10.1002/cac2.12367
N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA
Xiao Zheng, Qi Wang, You Zhou, Dachuan Zhang, Yiting Geng, Wenwei Hu, Changping Wu, Yufang Shi, Jingting Jiang
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/8/2022   doi:10.1002/cac2.12363

more papers...






Gastric cancer  

 

Edited by Yun Dai and Li Yan
 

This thematic series discusses the molecular classifications of gastric cancer by the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) as well as the implications in personalized therapeutic choices; discusses the evolution of gastric surgery and presents perspectives on surgical techniques in treating gastric cancer; and reviews current and emerging targeted agents as well as immunotherapies in treating gastric cancer. With these advancements in molecular characterization, surgical intervention, and targeted and immunotherapies, gastric cancer will enter a personalized medicine era in the next 5 years.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Tumor angiogenesis  

 

Edited by Francesco Pezzella
and Chao-Nan Qian 

Forming efficient vasculature network, also known as tumor angiogenesis, is a critical hallmark in tumor development. Explorations on its underlying molecular mechanisms have resulted in several novel anti-cancer drugs. However, the modest survival benefits from anti-angiogenic therapy have forced us to revisit our understanding on tumor angiogenesis. In this special issue, world-leading experts have contributed their critical thoughts to reveal alternative tumor angiogenesis approaches and potential treatment targets.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Lung cancer 


 

Edited by Lin Yan and Wei Zhang  

 

Lung cancer accounts for approximately 21% of worldwide cancer deaths and a staggering 1.6 million new cases are diagnosed every year. In China, lung cancer has become a particularly challenging disease because of air pollution and smoking. This thematic series discusses the proper use of targeted agents in treating lung cancer, reviews the application of biomarkers in clinical management and drug development, and analyzes the unique challenges in developing novel drugs for lung cancer in China.

 

Read thematic series > 



CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East,Guangzhou 510060, P.R.China